Market closed
Prices delayed by at least 15 minutes | Prices updated on 12 May 2025, 07.31 BST | Print
Maxcyte INC (MXCT)
COM STK USD0.01 (DI)This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
Address
22 Firstfield Road
Suite 110
Gaithersburg
MD
USA
20878
Telephone
+1 301 944-1700
Major shareholders
| Name | Amount | Holding (%) |
|---|---|---|
| Casdin Partners Master Fund, L.P. | 10,000,000 | 9.41 |
| BlackRock Inc | 7,570,052 | 7.12 |
| Sofinnova Crossover I SLP | 4,976,496 | 4.68 |
| Vitruvian Partners | 4,053,531 | 3.81 |
| Amati Global Investors Ltd | 3,937,491 | 3.70 |
| Bost-Jackson LLC | 3,790,088 | 3.56 |
| Legal & General Group PLC | 3,500,000 | 3.29 |
Key personnel
| Name | Position |
|---|---|
| Ms. Cynthia Lynne Collins | Director |
| Mr. Douglas J Swirsky | CHIEF FINANCIAL OFFICER |
| Mr. Stanley Charles Erck | Independent Director |
| Mr. Patrick J Balthrop Sr | Independent Director |
| Dr. Richard H. Douglas, PhD | Non-Executive Chairman of the Board |
| Mr. John Joseph Johnston | Independent Director |
| Dr. Yasir B. Al-Wakeel, B.M. | Independent Director |
| Mr. William Wade Brooke | Independent Director |
| Ms. Rekha Hemrajani, M.B.A. | Independent Director |
| Mr. Thomas M. Ross | EVP, GLOBAL SALES |
| Mr. Maher Masoud | Executive Director,President and Chief Executive Officer |
| Mr. David I. Sandoval | GENERAL COUNSEL |
| Mr. Ali Soleymannezhad | Chief Commercial Officer |
Forecast key dates
Previous key dates
Activity analysis
Geographical analysis
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.